You are here

Subscribe

Prostate & Urologic Cancer Center Blog

All
All

Duke Prostate & Urologic Cancer Center Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Jessica Hyland, Editor-In-Chief.

Shave The Date

Things have been quite hairy around Duke University the month of November. Join the MoDukes as they wrap up #Movember on Friday, Nov. 30 at 7 p.m. for the third annual “Bid Your Face Off” event at Fullsteam brewery. The event, which is a “Bid Your Face Off” auction gala, will feature creative...

DCI Launches Center for Prostate & Urologic Cancers

Duke Cancer Institute (DCI) officially launched the new DCI Center for Prostate & Urologic Cancers, a center of excellence supporting a growing multi-disciplinary clinical and translational research team. The DCI Center for Prostate & Urologic Cancers will be led by a multi-disciplinary...

New Prostate Cancer Prognostic Model For Enzalutamide

Researchers at the Duke Prostate & Urologic Cancer Center, led by genitourinary oncologist Andrew Armstrong, MD, have recently developed a novel nomogram, a prognostic model that measures overall survival for men with metastatic prostate cancer who were treated with enzalutamide, according to...

#RunYourStory: Surviving The Marathon

Physician burnout is at its highest level in history. According to a recent study in the American Journal of Medicine, physician-reported burnout increased significantly from 45.5 percent in 2011 to 54.4 percent in 2014. These numbers are also significantly higher than that of the general workforce...

Over 150 Men Screened For Prostate Cancer

This year, over 150 men participated in the annual Men's Health Initiative. For the past two decades, the Office of Health Equity at Duke Cancer Institute in partnership with Lincoln Community Health Center has co-hosted MHI, an outreach event aimed at screening men, particularly African American...

McNamara Receives PCF Young Investigator Award

Megan McNamara, MD, has been named one of 29 Prostate Cancer Foundation Young Investigator Award recipients for 2018. McNamara is also one of only eleven PCF Young Investigator Awardees conducting research to improve prostate cancer outcomes in U.S. veterans. The award includes three years of...

Duke Researchers Awarded $ 1 Million For Prostate Cancer Research

A team of researchers led by Duke Cancer Institute scientists Steven Patierno, PhD; Daniel George, MD; Jennifer Freedman, PhD; Jiaoti Huang, MD, PhD and Amanda Hargrove, PhD have been awarded a Movember Foundation-Prostate Cancer Foundation Challenge Award. The project includes a number of key co-...

Sound Waves Could Provide New Tool To Fight Cancer

Sound waves may become the next effective tool to help doctors diagnose cancer and develop more personalized diagnostics and treatments. A new study conducted by researchers from Duke University, MIT and Singapore's Nanyang Technological University shows that sound waves are capable of rapidly and...

Blurring The Racial Lines On Prostate Cancer

An increased survival benefit for African-American men with advanced prostate cancer and a stronger response to hormone therapy were the centerpieces of key racial disparity studies presented by researchers from Duke’s Prostate & Urologic Cancer Center at the 2018 American Society of Clinical...

Researchers Identify Promising New Drug Target for Lethal Prostate Cancer

Targeting a protein genome-binding process that directs expression of diverse cancerous genes could be an important new therapy approach for stopping the progression of late-stage prostate cancer, according to Duke researchers. The study , published Tuesday, May 29, 2018 in the journal Proceedings...

Tests Identify When Advanced Prostate Cancer Therapies Would Benefit

Two blood tests can predict which subset of men with advanced prostate cancer will likely not benefit from anti-androgen therapies, providing doctors and patient added clarity on treatment options, according to a study led by Duke Cancer Institute . The blood tests, dubbed “liquid biopsies”, detect...

Analysis: Survival Benefit for African-Americans with Advanced Prostate Cancer

Contrary to current perceptions, certain African-American men with advanced prostate cancer have as good a chance of survival as white men and might actually have a small advantage, according to a new analysis of more than 8,000 patients who participated in clinical trials. In a study presented...

Pages